HETERODIMERE VON GLUTAMINSÄURE
Patent europeic · EP3335736 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP3335736
- Numer da la dumonda
- EP18150494
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 07-11-2007
- Publitgà
- 20-06-2018
- Concedì
- 30-12-2020
- Stritgà
- 30-06-2022
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- A61K 51/00 (2006.01)C07B 59/00 (2006.01)C07C 275/16 (2006.01)C07C 275/24 (2006.01)C07C 275/30 (2006.01)C07C 311/19 (2006.01)C07D 213/38 (2006.01)A61P 35/00 (2006.01)A61K 39/385 (2006.01)
- Prioritad
- US 857490 P 08.11.2006US 878678 P 05.01.2007
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 30-06-2022
Stritgà, taxa betg pajada
Published in Swissreg on 30.06.2022
- 29-06-2022
Midada
Published in Swissreg on 29.06.2022
- 09-02-2022
Midada
Published in Swissreg on 09.02.2022
- 13-10-2021
Midada
Published in Swissreg on 13.10.2021
- 13-10-2021
Midada
Published in Swissreg on 13.10.2021
- 06-10-2021
Midada
Published in Swissreg on 06.10.2021
- 11-02-2021
Owner
- Owner
- Molecular Insight Pharmaceuticals, Inc., 160 Second Street, Cambridge, MA 02142, USA → Molecular Insight Pharmaceuticals, Inc., One World Trade Center, 47th Floor, Suite J, New York, NY 10007, USA
Published in Swissreg on 11.02.2021
- 30-12-2020
Concedì
Published in Swissreg on 30.12.2020
Partidas
Inventur
Tewksbury, MA 01876, US
New York, NY 10028, US
Topsfield, MA 01983, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.